These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24439061)

  • 1. The role of microRNA profiling in prognosticating progression in Ta and T1 urinary bladder cancer.
    Segersten U; Spector Y; Goren Y; Tabak S; Malmström PU
    Urol Oncol; 2014 Jul; 32(5):613-8. PubMed ID: 24439061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
    Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
    Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression Level of Urinary MicroRNA-146a-5p Is Increased in Patients With Bladder Cancer and Decreased in Those After Transurethral Resection.
    Sasaki H; Yoshiike M; Nozawa S; Usuba W; Katsuoka Y; Aida K; Kitajima K; Kudo H; Hoshikawa M; Yoshioka Y; Kosaka N; Ochiya T; Chikaraishi T
    Clin Genitourin Cancer; 2016 Oct; 14(5):e493-e499. PubMed ID: 27157639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage, grade and behavior of bladder urothelial carcinoma defined by the microRNA expression profile.
    Dip N; Reis ST; Timoszczuk LS; Viana NI; Piantino CB; Morais DR; Moura CM; Abe DK; Silva IA; Srougi M; Dall'Oglio MF; Leite KR
    J Urol; 2012 Nov; 188(5):1951-6. PubMed ID: 22999546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
    Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
    Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
    Baumgart S; Meschkat P; Edelmann P; Heinzelmann J; Pryalukhin A; Bohle R; Heinzelbecker J; Stöckle M; Junker K
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2725-2736. PubMed ID: 31552489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
    Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
    Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma.
    Won KY; Kim YW; Kim HS; Lee SK; Jung WW; Park YK
    Hum Pathol; 2013 Aug; 44(8):1648-55. PubMed ID: 23574781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome.
    Ratert N; Meyer HA; Jung M; Lioudmer P; Mollenkopf HJ; Wagner I; Miller K; Kilic E; Erbersdobler A; Weikert S; Jung K
    J Mol Diagn; 2013 Sep; 15(5):695-705. PubMed ID: 23945108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting progression of bladder urothelial carcinoma using microRNA expression.
    Rosenberg E; Baniel J; Spector Y; Faerman A; Meiri E; Aharonov R; Margel D; Goren Y; Nativ O
    BJU Int; 2013 Nov; 112(7):1027-34. PubMed ID: 23387295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31.
    Veerla S; Lindgren D; Kvist A; Frigyesi A; Staaf J; Persson H; Liedberg F; Chebil G; Gudjonsson S; Borg A; Månsson W; Rovira C; Höglund M
    Int J Cancer; 2009 May; 124(9):2236-42. PubMed ID: 19127597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Significant Upregulation of miR-886-5p in High Grade and Invasive Bladder Tumors.
    Khoshnevisan A; Parvin M; Ghorbanmehr N; Hatefi N; Galehdari H; Ziaee SA; Mowla SJ
    Urol J; 2015 Jul; 12(3):2160-4. PubMed ID: 26135932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A MicroRNA expression profile defining the invasive bladder tumor phenotype.
    Wszolek MF; Rieger-Christ KM; Kenney PA; Gould JJ; Silva Neto B; Lavoie AK; Logvinenko T; Libertino JA; Summerhayes IC
    Urol Oncol; 2011; 29(6):794-801.e1. PubMed ID: 19945312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer.
    Tsuchiyama K; Ito H; Taga M; Naganuma S; Oshinoya Y; Nagano K; Yokoyama O; Itoh H
    Prostate; 2013 Jun; 73(8):827-34. PubMed ID: 23184537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression.
    Fei X; Qi M; Wu B; Song Y; Wang Y; Li T
    FEBS Lett; 2012 Feb; 586(4):392-7. PubMed ID: 22265971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of Increased Expression of MicroRNA-155 in Bladder Cancer and Prognosis.
    Wang H; Men CP
    Lab Med; 2015; 46(2):118-22. PubMed ID: 25918190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
    Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
    Durkan GC; Nutt JE; Rajjayabun PH; Neal DE; Lunec J; Mellon JK
    Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
    Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
    J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.